Te­va, No­var­tis get fresh warn­ings from FTC over Or­ange Book patent list­ings

Last week
Pharma
Law

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

Last week
People

FDA ad­comm nar­row­ly votes against Uro­Gen’s blad­der can­cer drug, calls for RCTs

Last week
Pharma
FDA+

BioN­Tech in­vests £1B in grow­ing UK foot­print un­der ex­pand­ed pact with gov­ern­ment

Last week
Deals
R&D

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

Last week
Startups
In Focus

Mod­er­na pulls ap­pli­ca­tion for Covid-flu shot; An­oth­er IPO in Hong Kong

Last week
News Briefing

Co­caine vac­cine, a long­shot at­tempt to quell crav­ings, yields mixed da­ta in small study

Last week
R&D

Shut­ting down a de­men­tia care start­up

Last week
Health Tech

Genen­tech ex­pands deal with mol­e­c­u­lar glue biotech Ori­o­n­is for $105M up­front

Last week
Deals
R&D

How PureTech’s lung fi­bro­sis drug stacks up against the com­pe­ti­tion

Last week
R&D

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

Last week
Startups
Deals

Re­pro­duc­tive health biotech snags $65M to de­vel­op for­mer No­var­tis and Mer­ck KGaA drugs

Last week
Financing
Startups

UK biotech Ju­ve­nes­cence tar­gets $150M+ for 'healthy lifes­pan' drug can­di­dates

Last week
Financing
Startups

In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines

Last week
R&D
FDA+

Up­dat­ed: FDA ad­comm splits votes on Genen­tech and J&J can­cer drugs

Last week
FDA+

CRISPR Ther­a­peu­tics part­ners with siR­NA com­pa­ny, show­ing that gene edit­ing isn’t the on­ly an­swer

Last week
R&D
Cell/Gene Tx

RFK Jr. spars with sen­a­tors over re­search cuts, HHS bud­get plan

Last week
Pharma
FDA+

Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals

Last week
FDA+
Coronavirus

Tour­ma­line Bio's heart drug cuts in­flam­ma­tion as it seeks to com­pete with No­vo, CSL's as­sets 

Last week
R&D

SV Health’s $269M de­men­tia fund; Schrödinger lays off 7% of staff

Last week
News Briefing

Up­dat­ed: Trump ad­min­is­tra­tion re­veals 'most fa­vored na­tion' drug price coun­try tar­gets

Last week
Pharma
Law

Ex­clu­sive: Weight loss start­up Cal­i­brate swaps CEOs in lat­est lead­er­ship shake­up

Last week
People
Startups

Ex­clu­sive: Op­tura rais­es $6.5M to help eval­u­ate health­care AI pro­grams

Last week
Financing
Health Tech

Ex­clu­sive: At-home screen­ing start­up Repe­rio Health rais­es $14M

Last week
Financing
Diagnostics
First page Previous page 2345678 Next page Last page
A service from the Financial Times